
Godavari Biorefineries Limited has informed the Exchange regarding a press release dated December 17, 2025, titled "Sathgen Therapeutics Division of Godavari Biorefineries Ltd, India, expands to the U.S. with Launch of Princeton Based Subsidiary".
Filed with NSE · · 4 pages · English

Godavari Biorefineries Limited has informed the Exchange regarding a press release dated December 17, 2025, titled "Sathgen Therapeutics Division of Godavari Biorefineries Ltd, India, expands to the U.S. with Launch of Princeton Based Subsidiary".
Godavari Biorefineries Limited on 6ix
Follow Godavari Biorefineries into a list and get an email when it puts out news.
Follow Godavari Biorefineries